Loading chat...
VT S0154
Bill
AI Summary
- Requires health insurance plans and Medicaid to cover biomarker testing for diagnosis, treatment, management, and ongoing monitoring of diseases when supported by medical and scientific evidence
- Defines biomarker testing to include single-analyte tests, multiplex panel tests, protein expression analysis, and whole exome, genome, and transcriptome sequencing
- Coverage must be provided when testing is supported by FDA-approved indications, CMS coverage determinations, or nationally recognized clinical practice guidelines
- Requires coverage to be delivered in a manner that limits care disruptions, including avoiding the need for multiple biopsies or biospecimen samples
- Health insurance provisions take effect January 1, 2026 (with full implementation by January 1, 2027); Medicaid provisions take effect January 1, 2026 or upon CMS approval of any necessary state plan amendment
Legislative Description
An act relating to health insurance coverage for biomarker testing
Last Action
Favorable report with recommendation of amendment by Committee on Health and Welfare
3/17/2026
Committee Referrals
Health and Welfare1/23/2026
Finance5/9/2025
Full Bill Text
No bill text available